Saxelin M, Pessi T, Salminen S
Valio Ltd., R&D, Helsinki, Finland.
Int J Food Microbiol. 1995 Apr;25(2):199-203. doi: 10.1016/0168-1605(94)00091-j.
Recovery of the suggested probiotic strain Lactobacillus GG in feces was studied after oral administration. Lactobacillus GG was given to 20 healthy human volunteers for 7 days in gelatine capsules with daily doses of 1.6 x 10(8) cfu and 1.2 x 10(10) cfu. All the volunteers in the higher dose group had detectable numbers of Lactobacillus GG in their feces during the test period. The strain was detected in feces of all the volunteers after 3 days of administration. No effect was observed on the total number of fecal lactobacilli. Fecal detection of the strain may facilitate dose-response studies and provide a useful tool in dietary studies utilizing the strain in foods or food-type products.
口服给药后,对建议的益生菌菌株鼠李糖乳杆菌GG在粪便中的恢复情况进行了研究。将鼠李糖乳杆菌GG以明胶胶囊形式给予20名健康人类志愿者,为期7天,每日剂量分别为1.6×10⁸ cfu和1.2×10¹⁰ cfu。在测试期间,高剂量组的所有志愿者粪便中均可检测到鼠李糖乳杆菌GG的数量。给药3天后,在所有志愿者的粪便中均检测到该菌株。未观察到对粪便中乳酸杆菌总数的影响。该菌株的粪便检测可能有助于剂量反应研究,并为在食品或食品类产品中使用该菌株的饮食研究提供有用的工具。